Other Names
6-O-alpha-L-arabinopyranosyl-beta-D-glucopyranoside6-O-α-L-arabinopyranosyl-β-D-glucopyranosidevicianose glycosidevicianosideβ-vicianoside
A thorough review of the peer-reviewed scientific literature, government health body databases (NIH, NCCIH, EMA, EFSA), pharmacopeial monographs (USP, WHO, ESCOP, German Commission E), and established evidence databases reveals that beta-vicianoside is not a recognized dietary supplement ingredient and does not appear in any regulatory framework as a supplement, botanical preparation, or health product. It is a naturally occurring plant disaccharide glycoside moiety — a component of larger secondary metabolite molecules — studied exclusively in the context of plant biochemistry, plant defense ecology, and food flavor chemistry. No human clinical trials, controlled studies, or formal traditional-medicine preparations of isolated beta-vicianoside exist in the verifiable scientific record. The following article documents what is rigorously established in peer-reviewed plant science.
Beta-vicianoside is formally defined as the disaccharide 6-O-α-L-arabinopyranosyl-β-D-glucopyranoside (also written as 6-O-α-l-arabinopyranosyl-β-d-glucopyranoside). This disaccharide unit is the carbohydrate (glycone) portion found, for example, in the cyanogenic glycoside vicianin — where mandelonitrile is attached as the aglycone.
The disaccharide itself is called vicianose. Vicianin — the best-known natural compound carrying the beta-vicianoside moiety — is a cyanogenic glycoside containing vicianose. The name "beta-vicianoside" refers to the specific glycosidic linkage arrangement: an alpha-L-arabinopyranose sugar is linked through its 1-position to the 6-position of a beta-D-glucopyranose. This disaccharide, as a glycone, may be attached via a beta-glycosidic bond to a wide variety of aglycone molecules, producing a family of compounds collectively called beta-vicianosides.
Chemically, when the aglycone is mandelonitrile (in vicianin), the compound is defined as (R)-α-L-arabinopyranosyl-(1→6)-β-D-glucopyranosyloxy acetonitrile — a β-vicianoside in which mandelonitrile is beta-glycosidically linked to the disaccharide vicianose.
The term "beta-vicianoside" refers collectively to any compound in which the vicianose disaccharide is the glycone component linked via a beta-glycosidic bond. Well-characterized natural compounds carrying this moiety include:
L-arabinose, one of the component sugars of the vicianoside moiety, is notable for its sweet taste; research into β-vicianosides has included the chemical synthesis of 14 l-arabinose-containing disaccharides incorporating α-l-arabinopyranosyl-β-d-glucopyranoside structures with a diverse range of aroma aglycones.
Vicianin is a cyanogenic disaccharide; the enzyme vicianin beta-glucosidase uses (R)-vicianin and water to produce mandelonitrile and vicianose. It is found in seeds of Vicia angustifolia.
The cyanogenic disaccharide glycoside vicianin [mandelonitrile β-vicianoside (6-O-α-l-arabinopyranosyl-β-d-glucopyranoside)] is accumulated in seeds of Vicia angustifolia var. segetalis. The beta-vicianoside moiety is, however, far more widely distributed in the plant kingdom than this single species. Research has identified it across several major botanical families:
Beta-vicianoside does not exist in any isolated, purified, or standardized form available as a dietary supplement, botanical extract, or pharmaceutical preparation. The scientific literature contains references to:
No documented traditional medicine system — including Ayurveda, Traditional Chinese Medicine, European herbalism, indigenous American medicine, or any other formal ethnomedical tradition — has identified, named, or purposefully used isolated beta-vicianoside as a therapeutic agent. The term itself is a modern biochemical designation that would have been unknown to historical practitioners.
Plants containing beta-vicianoside-bearing compounds (particularly Vicia species) have had documented agricultural uses. The common vetch (Vicia sativa L.) seed is considered an ideal plant-based protein food for humans, but its edible value is mainly limited by the presence of cyanogenic glycosides that hydrolyze to produce toxic hydrogen cyanide (HCN). Accordingly, traditional use of Vicia seeds as food has historically required processing — such as boiling, soaking, or fermentation — specifically to detoxify cyanogenic glycoside content, rather than to exploit beta-vicianoside for any intended pharmacological benefit.
Vicia sativa grains may contain HCN, either free or in the form of cyanogenic glycosides. Hydrocyanic acid is a dangerous, rapidly acting poison for animals and humans, interfering with oxygen use at the cellular level and inhibiting cytochrome oxidase activity. Historical cultivation of common vetch was primarily for fodder and soil enrichment, not for human health applications.
Beta-vicianoside is not itself an active compound in the pharmacological sense; rather, it is a disaccharide glycone unit that determines the chemical behavior and biological activity of the larger molecule in which it is embedded. The identity of the aglycone (the non-sugar portion of the molecule) fundamentally determines biological function.
The catabolism of cyanogenic glycosides is initiated by cleavage of the carbohydrate moiety by one or more β-glycosidases, yielding the corresponding α-hydroxynitrile. Until relatively recently, the mode by which cyanogenic disaccharides are hydrolyzed was largely unclear; investigation of highly purified β-glycosidases from plants containing cyanogenic disaccharides has indicated that these compounds may be degraded via two distinct pathways. β-Glycosidases from Davallia trichomanoides and Vicia angustifolia hydrolyze (R)-vicianin and (R)-amygdalin at the aglycone–disaccharide bond, producing mandelonitrile and the corresponding disaccharide.
Vicianin hydrolase (VH) catalyzes the hydrolysis of vicianin into mandelonitrile and a disaccharide vicianose. Mandelonitrile is an unstable α-hydroxynitrile that spontaneously or enzymatically decomposes to release benzaldehyde and hydrogen cyanide (HCN). Cyanogenesis occurs rapidly only after cyanogenic plant tissues are macerated, allowing glycosides access to their catabolic enzymes. The possible nature of the compartmentation which prevents cyanogenesis under normal physiological conditions is discussed in relation to the tissue and subcellular localizations of cyanogens and catabolic enzymes.
Vicianin hydrolase shares about 50% identity with various kinds of plant beta-glycosidases including tea leaf beta-primeverosidase and furcatin hydrolase, and is classified in family 1 of the glycosyl hydrolases.
The VH transcript is detected abundantly in seeds and moderately in flowers, but only slightly in leaves, stems and roots, indicating that the organ distribution of VH expression is similar to that of the substrate vicianin.
Both native and recombinant VH enzymes hydrolyzed vicianin to release vicianose, demonstrating that VH is a disaccharide-specific beta-glycosidase. VH also hydrolyzed the mandelonitrile beta-glucoside prunasin to some extent but did not hydrolyze the gentiobioside amygdalin, both of which contain the same aglycone as vicianin. Thus, VH is a unique cyanogenic glycosidase showing high glycone specificity for the disaccharide vicianoside.
This enzyme exhibits strict specificity for the beta-vicianoside structure and shows highest activity toward (R)-vicianin with a Km of approximately 4.9 mM and optimal activity at pH 5.5.
Cyanogenic glycosides are naturally occurring plant secondary metabolites derived from amino acids, consisting of a sugar moiety with an α-hydroxynitrile-type aglycone attached to it. In Vicia species, the biosynthetic pathway from the amino acid phenylalanine to vicianin involves cytochrome P450 enzymes. The process of vicianin biosynthesis is distinct from the process of vicianin cyanogenesis that produces HCN; the key enzymes involved include CYP79 and CYP71A (cytochrome P450 enzymes) and UGT85B1 (UDP-glycosyltransferase).
For volatile alcohol vicianosides in plants beyond Vicia, a different biosynthetic mechanism operates. A UGT91R1 gene encodes a glycosyltransferase with specific catalytic activity toward (Z)-3-hexenol; this enzyme facilitates the β-D-glucopyranosyl arabinose conjugation of (Z)-3-hexenol, resulting in the biosynthesis of HexVic [(Z)-3-hexenyl β-vicianoside] in plant tissues.
The addition of the sugar moiety does not merely suppress the activity of the aglycone, and this reasoning does not fully explain the fact that the structures of the sugar moiety in plant glycosides are quite diverse. Research indicates that the specific disaccharide structure of beta-vicianoside, as opposed to a monosaccharide glucoside, appears to confer distinct biological properties to the resulting compound:
Important caveat: All scientific evidence described below pertains to the biological roles of beta-vicianosides in plant systems or their biochemical behavior. There are no human clinical trials, no animal pharmacological studies in therapeutic contexts, no pharmacokinetic studies in humans or animals, and no systematic reviews relating to any health-related application of beta-vicianoside in humans. The evidence below is therefore plant-biological and biochemical only.
Evidence type: Laboratory and controlled plant bioassay studies only. No evidence in any human or mammalian system.
Research has shown that (Z)-3-hexenyl vicianoside functions in plant defenses against insect herbivory. Exposure of tomato plants to volatile chemicals emitted from common cutworm-infested neighboring plants led to the accumulation of (Z)-3-hexenyl vicianoside [(Z)-3-hexenyl 6-O-α-L-arabinopyranosyl-β-d-glucopyranoside], which functions as a defense chemical against common cutworms. The aglycone (Z)-3-hexenol originates not from the volatile-exposed tomato plants but from infested ones, and the glycosylation of airborne (Z)-3-hexenol has been observed in various plant species.
Researchers demonstrated that (Z)-3-hexenol, the main biogenic volatile organic compound emitted from tomato (S. lycopersicum) plants after infestation with cutworms (Spodoptera litura), was received into a neighboring intact plant, which then showed defense against infestation by that worm. Non-targeted metabolome analysis showed that the incorporated (Z)-3-hexenol was accumulated as a glycoside conjugation (vicianoside) to acquire defense. This finding indicates that incorporated (Z)-3-hexenol is directly metabolized in the leaf tissues.
Research on volatile reception in tomato species in response to herbivory attack in neighboring plants has shown that a glycosyltransferase UGT91R1 is involved in glycosylation of (Z)-3-hexanyl β-D-glucopyranoside to (Z)-3-hexenyl β-D-vicianoside, which consequently hampers growth of the cutworm larvae when ingested.
Examination of the possibility that linalyl β-vicianoside contributes to defense against herbivores was conducted using soybean leaves exposed to linalool vapor. The available evidence in this area is entirely based on plant bioassay models and cannot be extrapolated to human or mammalian pharmacology.
Evidence type: Analytical chemistry and food science studies only. No clinical or nutritional intervention evidence.
Accumulations of metabolized biogenic volatile organic compounds, mainly glycosylated alcoholic BVOCs, have been found in several plants and are recognized as important aroma precursors — for example, in rose (Rosa damascena) petals, tea (Camellia sinensis) leaves, and wine grapes (Vitis spp.).
Plant-derived aroma glycosides are important sensory enhancers in food, beverages, cosmetics, and fragrance formulations and have considerable economic value. The β-vicianoside structural motif is one of two major disaccharide glycone types relevant to aroma precursor chemistry in plant foods.
The primeveroside synthesis method is also applicable to the synthesis of vicianosides. The hydrolysis rate of synthesized glycosides by crude tea enzyme shows that the main glycosidase is primeverosidase, and the enzyme mixture shows substrate specificity to both the carbohydrate and aglycone moieties.
A significant portion of aroma precursors accumulates in numerous food products as nonvolatile and flavorless glycoconjugates termed glycosidic aroma precursors. When subjected to enzymatic hydrolysis, these inert, nonvolatile glycosides undergo transformation into fragrant volatiles or volatiles that can generate odor-active compounds during food processing; microbial β-glucosidases play a pivotal role in enhancing the development of flavors during food and beverage processing.
Evidence type: Agricultural science and toxicology. No therapeutic studies.
The presence of the beta-vicianoside moiety in vicianin is directly implicated in the toxicological concern associated with certain legume species as food crops. Cyanogenesis describes the ability of living organisms to liberate hydrogen cyanide from stored cyanogenic glycosides upon tissue damage by hydrolysis and/or decomposition.
Cyanogenic glycosides, when ingested or chewed, produce hydrolyzed cyanide acid (HCN), which is one of the most potent poisons; hydrogen cyanide is extremely poisonous because it prevents cellular respiration.
The HCN contents of Vicia sativa seeds in developmental stages have been determined, and weighted gene coexpression network analysis has been used to explain the molecular regulatory mechanism of HCN synthesis. Eighteen key regulatory genes for HCN synthesis were identified, including the VsGT2, VsGT17 and CYP71A genes, as well as the VsGT1 gene family. VsGT1, VsGT2, VsGT17 and CYP71A jointly promoted HCN synthesis from 5 to 25 days after anthesis, with the HCN synthesis mainly regulated by VsGT1 from 25 to 35 days after anthesis.
In-depth elucidation of seed HCN synthesis is acknowledged to lay the foundations for breeding common vetch varieties with low HCN content.
There are no established associations between beta-vicianoside and human body systems or human health outcomes in the peer-reviewed literature or any regulatory health database. The compound has not been evaluated by the NIH Office of Dietary Supplements, NCCIH, EMA, EFSA, WHO, or any pharmacopeia for human health applications.
The only body-system relevance identified in the literature pertains to toxicological risk rather than therapeutic benefit: when vicianin (the cyanogenic beta-vicianoside of mandelonitrile) is hydrolyzed — whether by plant enzymes upon tissue damage or by digestive processes in consuming animals — it releases HCN. Vicia sativa grains may contain HCN, either free or in the form of cyanogenic glycosides; hydrocyanic acid is a dangerous, rapidly acting poison for animals and humans, interfering with oxygen use at the cellular level and inhibiting cytochrome oxidase activity.
No dosage forms or dosage recommendations for beta-vicianoside as a dietary supplement or therapeutic agent appear in any verifiable source. The compound is not available in any consumer product form. Laboratory quantities used in biochemical research are not translatable to or informative of human supplement dosing.
The only quantity mentioned in the available literature relates to a research enzyme kinetics experiment: the enzyme vicianin hydrolase was incubated with substrate at a concentration of 5 mM vicianin in a laboratory assay — a concentration figure pertaining exclusively to biochemical enzyme characterization and not to any biological exposure context.
The safety profile of beta-vicianoside as an isolated compound in humans is unknown, as it has not been studied in humans. The following source-backed considerations relate to the compound class:
Cyanogenic glycosides, when ingested or chewed, produce hydrolyzed cyanide acid (HCN); hydrogen cyanide is extremely poisonous because it prevents cellular respiration, specifically by preventing oxygen from being absorbed by blood cells. This applies specifically to the aglycone released upon hydrolysis of vicianin (mandelonitrile → HCN + benzaldehyde), not to beta-vicianoside as a disaccharide sugar unit per se.
Cyanogenesis occurs rapidly only after cyanogenic plant tissues are macerated, allowing glycosides access to their catabolic enzymes. The intact, unhydrolyzed glycoside is relatively inert; the cyanogenic danger arises on enzymatic or acidic hydrolysis of the glycosidic bond.
The manipulations targeted at making Vicia sativa seeds nutritionally useful are effective but costly and time consuming; it is therefore advisable to continue research on breeding of common vetch varieties that are valuable from an agronomic point of view and rich in protein but containing reduced levels of anti-nutritional factors. This reflects a regulatory and agricultural science context, not a supplement safety assessment.
Non-cyanogenic beta-vicianosides — such as (Z)-3-hexenyl β-vicianoside or linalyl β-vicianoside — carry aglycones that are not cyanogenic. The aglycone (Z)-3-hexenol, for instance, is a common green-leaf volatile present in many foods and regarded as generally safe. However, no formal safety assessment of isolated non-cyanogenic beta-vicianosides has been conducted in any regulatory framework.
No pharmacokinetic data, drug interaction studies, or human exposure studies for any isolated beta-vicianoside compound exist in the verifiable literature. Any claim of specific drug interactions would be unsubstantiated.
The total body of published scientific evidence on beta-vicianoside as it relates to human health is as follows:
The scientific evidence is exclusively preliminary and confined to plant systems. Beta-vicianoside does not fulfill the evidentiary basis required to characterize it as a dietary supplement ingredient with demonstrated or plausible human health benefits. Any commercial representation of it as a health ingredient would go substantially beyond the available peer-reviewed evidence.
Health conditions that Beta vicianoside may help support.
Body systems that Beta vicianoside may help support.